Find clinical trials for Eczema in New York, NY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Eczema trials near New York, NY, USA:
effective for the treatment of atopic dermatitis (AD), also known as eczema, or atopic eczema. People with this condition may have ...
Phase 2
The Bronx, New York, United States and 32 other locations
The purpose of this study is to evaluate the safety and efficacy of long-term treatment with IMG-007 in participants with moderate-to-severe atopic d...
Phase 2
New York, New York, United States and 22 other locations
The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.
Phase 2
New York, New York, United States and 39 other locations
This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.
Phase 2
New York, New York, United States and 84 other locations
This is a first-in-human, Phase 1, double-blind, randomized, placebo-controlled, dose-escalation study evaluating ARQ-234. The study is designed to a...
Phase 1
Fair Lawn, New Jersey, United States and 5 other locations
The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema ...
Phase 4
New York, New York, United States and 71 other locations
The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to \<18...
Phase 3
East Windsor, New Jersey, United States of America and 88 other locations
This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB75...
Phase 2
New York, New York, United States and 88 other locations
The primary objective of the study is to assess the long-term safety of dupilumab in pediatric participants with AD.The secondary objectives of the s...
Phase 3
New York, New York, United States and 83 other locations
This study evaluates ATI-045 versus placebo in patients with Moderate-to-Severe Atopic Dermatitis.
Phase 2
New York, New York, United States and 60 other locations
Clinical trials
Research sites
Resources
Legal